ID   FO [Mouse myeloma]
AC   CVCL_6972
SY   F/0
DR   CLO; CLO_0003377
DR   AddexBio; C0003017/4886
DR   ATCC; CRL-1646
DR   BCRC; 60040
DR   CCRID; 1101MOU-PUMC000821
DR   CCRID; 3101MOUTCM31
DR   KCB; KCB 2014046YJ
DR   Wikidata; Q54835100
RX   PubMed=7009747;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse plasma cell myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 15
//
RX   PubMed=7009747; DOI=10.1016/0022-1759(80)90146-5;
RA   de St Groth S.F., Scheidegger D.;
RT   "Production of monoclonal antibodies: strategy and tactics.";
RL   J. Immunol. Methods 35:1-21(1980).
//